CellCentric Company

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
Technology: Data-driven Technologies
Industry: PharmTech
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2003
Employees Number: 1-10
Funding Status: N/A
Investors Number: 9
Total Funding: $42.6M
Estimated Revenue: $10M to $50M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership